Combining chemotherapy with a BRAF oncogene inhibitor proves effective at treating this disease in a mouse model. This alternative paves the way toward a new approach for patients affected by this type of tumor, which has no cure in the most advanced stages or cases of relapse.
Комментариев нет:
Отправить комментарий